Are complement factor H autoantibodies associated with early stage NSCLC?
These findings suggest that in patients with NSCLC, CFH autoantibody is a molecular marker associated with early-stage disease.
Our finding provides the first evidence suggesting that a functional polymorphism in the regulatory region of serotonin transporter gene may be associated with suicide in depressed subjects.